Category Science and Technology
Yeyang Su invites Impact Ethics readers to mark their calendars for the second International Summit on Human Genome Editing.
Marc-André Gagnon dispels misconceptions about the benefits of private health insurance plans and argues in favour of a universal model for pharmacare.
Landon J. Getz explores the privacy minefield of commercial DNA Sequencing, and how it has become relevant in recent news.
Katie Hammond argues that discussions surrounding the Assisted Human Reproduction Act must go beyond decriminalization.
Michele Battle-Fisher calls for deeper ethical scrutiny of unregulated and experimental medical interventions.
Dylan Roskams-Edris warns about the habit forming and addictive capacities of smartphone apps and explains the need for an ethics of apps.
Francine Coeytux, Marcy Darnovsky, Susan Berke Fogel, and Emily Galpern maintain that the development of new regulations about assisted reproductive technologies must include the voices of scholars who have studied women’s health issues, and advocates who have worked for policies and practices that safeguard women’s health and rights.